Theravance Biopharma (TBPH) Earnings Date & Reports

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

TBPH is expected to report earnings to fall 28.48% to -22 cents per share on May 13

Theravance Biopharma TBPH Stock Earnings Reports

Q1'25

Est.

$-0.22

Q4'24

Missed

by $0.11

Q3'24

Missed

by $0.03

Q2'24

Missed

by $0.13

Q1'24

Beat

by $0.01

The last earnings report on February 26 showed earnings per share of -31 cents, missing the estimate of -20 cents. With 236.35K shares outstanding, the current market capitalization sits at 445.73M.

View a ticker or compare two or three

Compare

TBPH